O. V. Kolenko, N. V. Postupaeva, A. V. Postupaev, E. L. Sorokin
{"title":"微脉冲光凝治疗急性闭角型青光眼疗效观察","authors":"O. V. Kolenko, N. V. Postupaeva, A. V. Postupaev, E. L. Sorokin","doi":"10.17816/ov258607","DOIUrl":null,"url":null,"abstract":"BACKGROUND: An improved technique of cyclophotocoagulation appeared cyclophotocoagulation in micropulse mode with splitting of the continuous stream of laser energy into short micropulse series with intervals. \nAIM: The aim of the study is to clinically evaluate the efficacy and the safety of micropulse cyclophotocoagulation for acute angle-closure glaucoma jugulation. \nMATERIALS AND METHODS: In the study, 14 patients with acute angle-closure glaucoma with 37 days duration were included. The mean intraocular pressure was 35.1 2.4 mm Hg against the background of hypotensive therapy, best corrected visual acuity was from 0.005 to 0.3. All patients on admission underwent laser iridotomy, consistent peripheral colobomas of the iris were obtained. On the following day, taking into account the intraocular pressure level of 3036 mm Hg against the background of hypotensive therapy, all patients underwent micropulse cyclophotocoagulation with Cyclo G6 Glaucoma Laser System (USA). \nRESULTS: After surgery, there were no complications noted. The pain syndrome was completely eliminated in all patients on the first day after the procedure. Intraocular pressure decreased in average to 18.1 2.8 mm Hg. Within 318 months after micropulse cyclophotocoagulation, phacoemulsification was performed in 9 eyes. During the 2 years of the follow-up period, intraocular pressure in all eyes remained normal, from 16 to 23 mm Hg, best-corrected visual acuity varied from 0.4 to 0.9. \nCONCLUSIONS: Cyclophotocoagulation in micropulse mode allowed an effective and safe lowering of intraocular pressure to normal values in all eyes with acute angle-closure glaucoma; this provided pain relief and preservation of visual functions during the follow-up period up to 2 years.","PeriodicalId":10836,"journal":{"name":"Current Ophthalmology Reports","volume":null,"pages":null},"PeriodicalIF":0.9000,"publicationDate":"2023-07-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Efficacy of micropulse cyclophotocoagulation in acute angle-closure glaucoma\",\"authors\":\"O. V. Kolenko, N. V. Postupaeva, A. V. Postupaev, E. L. Sorokin\",\"doi\":\"10.17816/ov258607\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"BACKGROUND: An improved technique of cyclophotocoagulation appeared cyclophotocoagulation in micropulse mode with splitting of the continuous stream of laser energy into short micropulse series with intervals. \\nAIM: The aim of the study is to clinically evaluate the efficacy and the safety of micropulse cyclophotocoagulation for acute angle-closure glaucoma jugulation. \\nMATERIALS AND METHODS: In the study, 14 patients with acute angle-closure glaucoma with 37 days duration were included. The mean intraocular pressure was 35.1 2.4 mm Hg against the background of hypotensive therapy, best corrected visual acuity was from 0.005 to 0.3. All patients on admission underwent laser iridotomy, consistent peripheral colobomas of the iris were obtained. On the following day, taking into account the intraocular pressure level of 3036 mm Hg against the background of hypotensive therapy, all patients underwent micropulse cyclophotocoagulation with Cyclo G6 Glaucoma Laser System (USA). \\nRESULTS: After surgery, there were no complications noted. The pain syndrome was completely eliminated in all patients on the first day after the procedure. Intraocular pressure decreased in average to 18.1 2.8 mm Hg. Within 318 months after micropulse cyclophotocoagulation, phacoemulsification was performed in 9 eyes. During the 2 years of the follow-up period, intraocular pressure in all eyes remained normal, from 16 to 23 mm Hg, best-corrected visual acuity varied from 0.4 to 0.9. \\nCONCLUSIONS: Cyclophotocoagulation in micropulse mode allowed an effective and safe lowering of intraocular pressure to normal values in all eyes with acute angle-closure glaucoma; this provided pain relief and preservation of visual functions during the follow-up period up to 2 years.\",\"PeriodicalId\":10836,\"journal\":{\"name\":\"Current Ophthalmology Reports\",\"volume\":null,\"pages\":null},\"PeriodicalIF\":0.9000,\"publicationDate\":\"2023-07-14\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Current Ophthalmology Reports\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.17816/ov258607\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q4\",\"JCRName\":\"OPHTHALMOLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Current Ophthalmology Reports","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.17816/ov258607","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"OPHTHALMOLOGY","Score":null,"Total":0}
引用次数: 0
摘要
背景:在微脉冲模式下,将连续的激光能量流分裂成有间隔的短微脉冲序列,出现了一种改进的循环光凝技术。目的:临床评价微脉冲光凝治疗急性闭角型青光眼的疗效和安全性。材料与方法:本研究纳入急性闭角型青光眼患者14例,病程37 d。在降压治疗背景下,平均眼压为35.1 ~ 2.4 mm Hg,最佳矫正视力为0.005 ~ 0.3。所有患者入院时均行激光虹膜切开术,获得一致的虹膜周围结肠瘤。第二天,在降压治疗背景下,考虑到眼压水平为3036 mm Hg,所有患者均采用美国Cyclo G6青光眼激光系统进行微脉冲光凝治疗。结果:术后无并发症发生。所有患者术后第一天疼痛综合征完全消除。眼压平均下降至18.1 2.8 mm Hg。微脉冲光凝术后318个月内,9眼行超声乳化术。随访2年,眼内压16 ~ 23 mm Hg正常,最佳矫正视力0.4 ~ 0.9。结论:微脉冲模式下的光凝治疗可有效、安全地将急性闭角型青光眼患者的眼压降至正常值;在长达2年的随访期间,这提供了疼痛缓解和视觉功能的保存。
Efficacy of micropulse cyclophotocoagulation in acute angle-closure glaucoma
BACKGROUND: An improved technique of cyclophotocoagulation appeared cyclophotocoagulation in micropulse mode with splitting of the continuous stream of laser energy into short micropulse series with intervals.
AIM: The aim of the study is to clinically evaluate the efficacy and the safety of micropulse cyclophotocoagulation for acute angle-closure glaucoma jugulation.
MATERIALS AND METHODS: In the study, 14 patients with acute angle-closure glaucoma with 37 days duration were included. The mean intraocular pressure was 35.1 2.4 mm Hg against the background of hypotensive therapy, best corrected visual acuity was from 0.005 to 0.3. All patients on admission underwent laser iridotomy, consistent peripheral colobomas of the iris were obtained. On the following day, taking into account the intraocular pressure level of 3036 mm Hg against the background of hypotensive therapy, all patients underwent micropulse cyclophotocoagulation with Cyclo G6 Glaucoma Laser System (USA).
RESULTS: After surgery, there were no complications noted. The pain syndrome was completely eliminated in all patients on the first day after the procedure. Intraocular pressure decreased in average to 18.1 2.8 mm Hg. Within 318 months after micropulse cyclophotocoagulation, phacoemulsification was performed in 9 eyes. During the 2 years of the follow-up period, intraocular pressure in all eyes remained normal, from 16 to 23 mm Hg, best-corrected visual acuity varied from 0.4 to 0.9.
CONCLUSIONS: Cyclophotocoagulation in micropulse mode allowed an effective and safe lowering of intraocular pressure to normal values in all eyes with acute angle-closure glaucoma; this provided pain relief and preservation of visual functions during the follow-up period up to 2 years.
期刊介绍:
This journal aims to offer expert review articles on the most significant recent developments in the field of ophthalmology. By providing clear, insightful, balanced contributions, the journal intends to serve those who diagnose, treat, manage, and prevent ocular conditions and diseases. We accomplish this aim by appointing international authorities to serve as Section Editors in key subject areas across the field. Section Editors select topics for which leading experts contribute comprehensive review articles that emphasize new developments and recently published papers of major importance, highlighted by annotated reference lists. An Editorial Board of more than 20 internationally diverse members reviews the annual table of contents, ensures that topics include emerging research, and suggests topics of special importance to their country/region. Topics covered may include age-related macular degeneration; diabetic retinopathy; dry eye syndrome; glaucoma; pediatric ophthalmology; ocular infections; refractive surgery; and stem cell therapy.